explore -WSS

explore

author：knowledge 2025-09-07 21:52:16 - browse：6

Adam's take main illustration — Molly Ferguson/STAT

This week, a preview of the TUDCA study in ALS and thoughts on how it might impact Amylyx Pharmaceuticals. Also, I chatted with CRISPR Therapeutics CEO Sam Kulkarni about its new investor. Read to the end for some burning questions, random thoughts.

The next ALS data readout — overdue but important

A European academic consortium is expected to announce results soon from a clinical trial investigating the use of a widely available nutritional supplement called tauroursodeoxycholic acid, or TUDCA, in people living with ALS. The outcome of the TUDCA-ALS study could have implications for Amylyx Pharmaceuticals, because TUDCA is one of the two main ingredients in Relyvrio, the company’s approved drug for ALS.

In a recent interview at Amylyx’s Kendall Square headquarters, co-CEOs Justin Klee and Josh Cohen mostly downplayed the suggestion that results from the randomized, placebo-controlled TUDCA study might affect Relyvrio negatively, or even positively.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Novo acquires Inversago for up to $1 billion

Wikipedia

WSS

Caregivers of transplant patients call for more support, training

CDC overhauls leadership of center that led response to Covid

Maui funeral service workers on devastation of fires: 'I'm in shock'

CDC overhauls leadership of center that led response to Covid

Readout LOUD podcast: 2023 in review, and a look at biotech in 2024

DeSantis can now import cheaper drugs. But will Biden get credit?

focus

explore

The next ALS data readout — overdue but important

focus

As demand for Covid shots wanes, Moderna seeks its next success

An innovative path out of biotech’s “valley of death”

United colonoscopy coverage change 'may cost lives,' doctors say

Listen: Your guide to Wegovy's blockbuster heart study

How to save PrEP access — and even expand it

Maui funeral service workers on devastation of fires: 'I'm in shock'

BioMarin wins approval for gene therapy to treat hemophilia A

DeSantis can now import cheaper drugs. But will Biden get credit?

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Maui funeral service workers on devastation of fires: 'I'm in shock'

explore

Where are patients getting their prescriptions for GLP

Some of the ways extreme heat will change life as we know it

Covid's long

The history of OxyContin, told through Purdue Pharma documents

Pharma budget tightening trickles down to Doximity

Presidential candidate assassinated in Ecuador, 1 suspect dead and 6 arrested

Wikipedia

Wikipedia

Wikipedia

hotspot